Email This Article

Genzyme's Big Bet on Cancer
By Robert Steyer
04/14/04 - 03:17 PM EDT
The biotech's plan to buy Ilex Oncology may draw more questions than its quarterly results.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,319.75 1,094.03 2,147.75 32.29
Oil *
76.64
DOWN
144.65
DOWN
16.60
DOWN
28.30
DOWN
0.50
10 Yr
3.23%
SPDR Gold
115.47
-1.38%
-1.49%
-1.30%
-1.52%
Data delayed 20 minutes

Brokerage Partners